Annual report pursuant to Section 13 and 15(d)

Common Stock Warrants and Options (Details Narrative)

v3.25.0.1
Common Stock Warrants and Options (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Oct. 17, 2024
May 31, 2023
Jan. 31, 2023
Apr. 30, 2022
Dec. 31, 2024
Dec. 31, 2023
Jan. 01, 2023
Dec. 31, 2022
Options outstanding intrinsic value         $ 22,000      
Common stock awards granted         23,335 83,333    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number         124,600 126,265   54,348
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period         25,935      
Share-based compensation arrangement by share-based payment award, options, exercisable, weighted average remaining contractual term         8 years 3 months 18 days      
Options vested and exercisable intrinsic value         $ 18,000      
Purchase an aggregate 23,335 83,333 83,333          
Price per share $ 2.11 $ 25.50         $ 10.50  
Expiry period 10 years 10 years 10 years          
Share vested value 45,000 1,600,000 1,600,000          
Fair value of vested stock options         $ 230,000 $ 1,770,000    
Stock option, vested         105,802      
Stock option, exercisable         105,802      
Stock option, unvested compensation         $ 30,000      
Omnibus Incentive Plan [Member]                
Common stock awards granted       166,667        
Available for grant         16,132      
Common Stock [Member]                
Options outstanding intrinsic value         $ 0      
Fair value of vested stock options